Astec LifeSciences LimitedASTECNSE
Outcome of Rights Issue Committee Meeting held on July 02, 2025
As filed · Astec LifeSciences Limited has informed the Exchange regarding Outcome of Rights Issue Committee Meeting held on July 02, 2025.
CapitalWatchNotablemateriality 69 out of 100
What happened
FactAstec LifeSciences Limited has proposed a Rights Issue of up to 28,01,673 equity shares at an issue price of ₹890.00 each, aggregating approximately ₹249.35 Crore, to eligible shareholders in the ratio of 1 share for every 7 shares held as of the record date, July 4, 2025. The Rights Issue Committee has approved the Letter of Offer, which is available on the company's website. The filing has been made with BSE, NSE, and SEBI.
Why it matters
CapitSignal interpretationExisting holders can maintain their stake only by putting in more money; those who do not subscribe are diluted.
Watch next
Fact- Rights ratio and issue price
- Record date and subscription window
- Promoter intention to subscribe
Evidence
How CapitSignal classified this
- Reasoning:
- RIGHTS_ISSUE base 64; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%